Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ: 072020)

Market Cap	96.45B
Revenue (ttm)	39.19B
Net Income (ttm)	3.65B
Shares Out	9.56M
EPS (ttm)	375.11
PE Ratio	26.90
Forward PE	n/a
Dividend	150.00 (1.50%)
Ex-Dividend Date	n/a

Volume	26,707
Open	9,920
Previous Close	9,910
Day's Range	9,840 - 10,010
52-Week Range	9,470 - 11,790
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About Choong Ang Vaccine Laboratory

Choong Ang Vaccine Laboratory Co., Ltd., operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea. Its vaccine products include SuiShot, PoulShot, CaniShot, BoviShot, FeliShot, RabbiShot, and AquaShot for preventing diseases and infection in pigs, poultry, dogs, cattle, cats, rabbits, and fish. The company was founded in 1968 and is based in Daejeon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1968
• Employees: 167
• Stock Exchange: KOSDAQ
• Ticker Symbol: 072020

Financial Performance

In 2022, Choong Ang Vaccine Laboratory's revenue was 39.30 billion, a decrease of -3.95% compared to the previous year's 40.91 billion. Earnings were 4.04 billion, a decrease of -46.80%.